Glecaprevir | B2347

Glecaprevir is a hepatitis C virus nonstructural protein 3/4A protease inhibitor that targets the viral RNA replication.

Glecaprevir is a hepatitis C virus nonstructural protein 3/4A protease inhibitor that targets the viral RNA replication.

B2347 | Glecaprevir DataSheet

Alternate Name/Synonyms: ABT-493,ABT493,(33R,35S,91R,92R,5S,E)-5-(tert-butyl)-N-((1R,2R)-2-(difluoromethyl)-1-(((1-methylcyclopropyl)sulfonyl)carbamoyl)cyclopropyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35-carboxamide

Appearance: Crystalline solid

Formulation:

CAS Number: 1365970-03-1

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: N/A

Molecular Formula: C₃₈H₄₆F₄N₆O₉S

Molecular Weight: 838.87

Cell-Permeable?: TRUE

Purity: ≥98%

Solubilities: >50 mg/ml (DMSO)

Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.

Country of Origin: USA

Tag Line: A Hepatitis C Virus NS3/4A Protease Inhibitor

MDL Number:

PubChem CID: 66828839

SMILES: CC1(CC1)S(=O)(=O)NC(=O)C2(CC2C(F)F)NC(=O)C3CC4CN3C(=O)C(NC(=O)OC5CCCC5OCC=CC(C6=NC7=CC=CC=C7N=C6O4)(F)F)C(C)(C)C

InChi: InChI=1S/C38H46F4N6O9S/c1-35(2,3)28-32(50)48-19-20(17-24(48)30(49)46-37(18-21(37)29(39)40)33(51)47-58(53,54)36(4)14-15-36)56-31-27(43-22-9-5-6-10-23(22)44-31)38(41,42)13-8-16-55-25-11-7-12-26(25)57-34(52)45-28/h5-6,8-10,13,20-21,24-26,28-29H,7,11-12,14-19H2,1-4H3,(H,45,52)(H,46,49)(H,47,51)/b13-8+/t20-,21+,24+,25-,26-,28-,37-/m1/s1

InChi Key: MLSQGNCUYAMAHD-ITNVBOSISA-N